These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25526438)

  • 1. Prior to the oral therapy, what do we know about HCV-4 in Egypt: a randomized survey of prevalence and risks using data mining computed analysis.
    Abd Elrazek AE; Bilasy SE; Elbanna AEM; Elsherif AEA
    Medicine (Baltimore); 2014 Dec; 93(28):e204. PubMed ID: 25526438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of HCV induced-Esophageal varices in Egypt: Valuable knowledge using data mining analysis.
    Abdel-Aty M; Fouad M; Sallam MM; Elgohary EA; Ismael A; Nawara A; Hawary B; Tag-Adeen M; Khaled S
    Medicine (Baltimore); 2017 Jan; 96(4):e5647. PubMed ID: 28121921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial.
    Waked I; Shiha G; Qaqish RB; Esmat G; Yosry A; Hassany M; Soliman R; Mohey MA; Allam N; Zayed N; Asselah T; Hall C; Redman R; Mobashery N; Doss W
    Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):36-44. PubMed ID: 28404110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of schistosomiasis and hepatitis on liver disease.
    Halim AB; Garry RF; Dash S; Gerber MA
    Am J Trop Med Hyg; 1999 Jun; 60(6):915-20. PubMed ID: 10403320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni.
    Kamal S; Madwar M; Bianchi L; Tawil AE; Fawzy R; Peters T; Rasenack JW
    Liver; 2000 Jul; 20(4):281-9. PubMed ID: 10959806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real life application of FIB-4 & APRI during mass treatment of HCV genotype 4 with directly acting anti-viral agents in Egyptian patients, an observational study.
    Said M; Soliman Z; Daebes H; M El-Nahaas S; El-Serafy M
    Expert Rev Gastroenterol Hepatol; 2019 Dec; 13(12):1189-1195. PubMed ID: 31702417
    [No Abstract]   [Full Text] [Related]  

  • 7. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
    Shiha G; Soliman R; Mikhail NNH; Easterbrook P
    J Hepatol; 2020 Apr; 72(4):658-669. PubMed ID: 31734097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience.
    Mangia A; Susser S; Piazzolla V; Agostinacchio E; De Stefano G; Palmieri V; Spinzi G; Carraturo I; Potenza D; Losappio R; Arleo A; Miscio M; Santoro R; Sarrazin C; Copetti M
    J Hepatol; 2017 Apr; 66(4):711-717. PubMed ID: 27965158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of sustained virological response in Greek and Egyptian patients with hepatitis C genotype 4: does ethnicity matter?
    Papastergiou V; Dimitroulopoulos D; Skorda L; Lisgos P; Ketikoglou I; Kostas N; Karatapanis S
    J Med Virol; 2012 Aug; 84(8):1217-23. PubMed ID: 22711349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained virological response: a milestone in the treatment of chronic hepatitis C.
    Morisco F; Granata R; Stroffolini T; Guarino M; Donnarumma L; Gaeta L; Loperto I; Gentile I; Auriemma F; Caporaso N
    World J Gastroenterol; 2013 May; 19(18):2793-8. PubMed ID: 23687416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy.
    Sagnelli E; Stroffolini T; Sagnelli C; Cacopardo B; Andriulli A; Babudieri S; Coppola N; Gaeta GB; Almasio PL
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):676-681. PubMed ID: 29465473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence.
    Gad A; Tanaka E; Matsumoto A; el-Hamid Serwah A; Ali K; Makledy F; el-Gohary A; Orii K; Ijima A; Rokuhara A; Yoshizawa K; Nooman Z; Kiyosawa K
    J Med Virol; 2003 Aug; 70(4):594-9. PubMed ID: 12794722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.
    Bellentani S; Pozzato G; Saccoccio G; Crovatto M; Crocè LS; Mazzoran L; Masutti F; Cristianini G; Tiribelli C
    Gut; 1999 Jun; 44(6):874-80. PubMed ID: 10323892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic hepatitis C in Asia: when East meets West.
    Yu ML; Chuang WL
    J Gastroenterol Hepatol; 2009 Mar; 24(3):336-45. PubMed ID: 19335784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients.
    El-Shamy A; Shoji I; El-Akel W; Bilasy SE; Deng L; El-Raziky M; Jiang DP; Esmat G; Hotta H
    J Clin Microbiol; 2012 Dec; 50(12):3886-92. PubMed ID: 22993188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral hepatitis C infection among Egyptians the magnitude of the problem: epidemiological and laboratory approach.
    Mohamed MK; Rakhaa M; Shoeir S; Saber M
    J Egypt Public Health Assoc; 1996; 71(1-2):79-111. PubMed ID: 17217003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
    Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
    World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection.
    Udompap P; Mannalithara A; Heo NY; Kim D; Kim WR
    J Hepatol; 2016 May; 64(5):1027-1032. PubMed ID: 26809112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.
    Roulot D; Bourcier V; Grando V; Deny P; Baazia Y; Fontaine H; Bailly F; Castera L; De Ledinghen V; Marcellin P; Poupon R; Bourlière M; Zarski JP; Roudot-Thoraval F;
    J Viral Hepat; 2007 Jul; 14(7):460-7. PubMed ID: 17576387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit.
    Bert F; Rindermann A; Abdelfattah MA; Stahmeyer JT; Rossol S
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1246-52. PubMed ID: 27439034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.